HIV Diagnosis & Treatment Market is Expected to Grow at a CAGR of 3.3% from 2016 to 2023

Market Highlights

The Middle East and Africa HIV Diagnosis & Treatment Market has been evaluated as moderately growing market and it is expected that the market will continue to grow similarly in the near future. HIV (human immunodeficiency virus) kills body’s immune cells and can lead to AIDS (Acquired Immunodeficiency Syndrome). It is deadly disease and there is no cure for it. While number of HIV cases are decreasing in other part of the world, rate of new HIV infection is increasing rapidly in Middle East and Africa region. Around 19 million people in Eastern and Northern Africa and about 2.7 million people in Middle East and Africa (MENA) are suffering from deadly HIV.  Since 2001, the number of deaths because of AIDS are almost doubled in this region. Use of contaminated blood and organ transplant are leading to increase in number of HIV cases. Increasing cases of drug of abuse and unsafe medical practices are driving the growth for the market. HIV mostly spread through commercial *** networks. South African region contributes about 40% of region’s new HIV infection cases. HIV prevalence in Middle East is as low as 0.1% but increasing migration and dug of abuse, the number of HIV infected cases are growing. Major drugs manufacturers are spending money to develop effective drug to cure HIV which is key factor for the growth of the market. However, some factors are inhibiting the growth for the market in this region such as lack of awareness of the diseases, limited access to the healthcare facilities, availability of drugs and treatments, cost of drugs and treatments etc.

Middle East and Africa HIV Diagnosis & Treatment Market was about US$ 1.65 billion in 2016 and is expected to reach US$ 2.07 billion by 2023 at a CAGR of 3.3%.

Key Players for Middle East and Africa HIV Diagnosis & Treatment Market:

  • Abbott Laboratories (US),
  • Boehringer Ingelheim GmbH (Germany),
  • Bristol-Myers Squibb Company (US),
  • Cipla Inc. (India),
  • Hoffmann-La Roche Ltd (Switzerland),
  • Gilead (US),
  • GlaxoSmithKline plc. (UK),
  • Johnson & Johnson Services, Inc.(US),
  • ViiV Healthcare group of companies (UK),
  • Merck & Co., Inc. (US).

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2990

As compared to other regions, the HIV Diagnosis & Treatment industry in Africa contributes largest share in this region. High prevalence of this disease in Africa, especially in south and east region of Africa is one of the major factor for the growth of HIV Diagnosis & Treatment market such as HIV drugs, HIV Treatment etc. Out of total HIV positive people worldwide, about 69% are living in the sub-Saharan Africa. There are approximate 23.8 million people are infected in this region. Out of total number of HIV positive children, about 91% are living in Africa. Increasing role of many organizations such as WHO and other NGOs are playing major role in the growth of the market. However factors like lack of awareness about the diseases, lack of access to the drugs and treatment and cost of the treatment are prohibiting the growth for the market in this region.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Middle East and Africa HIV Diagnosis & Treatment Market – Forecast To 2023

 Table of Content

  1.  Report Prologue
    2.    Introduction

    2.1    Definition
    2.2    Scope of the Study
    2.2.1    Research Objective
    2.2.2    Assumptions
    2.2.3    Limitations
    2.3    Market Structure
    2.4.    Market Segmentation
    3.    Research Methodology
    3.1    Research Process
    3.2    Primary Research
    3.3    Secondary Research
    3.4    Market Size Estimation
    3.5    Forecast Model
    4.    Market Dynamics
    4.1    Drivers
    4.2    Restraints
    4.3    Opportunities
    4.4    Mega Trends
    4.5    Macroeconomic Indicators
    5.    Market Factor Analysis

Continue………..

Related Report

Cardiac rehabilitation devices market information, by type (recumbent cross trainer, treadmill, elliptical, stationary bicycle, training balls, heart rate monitors, blood flow monitors, and others), by end users (hospitals, clinic, cardiac care centers, rehab centers, and others) – Forecast to 2022.Know more about this report @ https://www.marketresearchfuture.com/reports/cardiac-rehabilitation-devices-market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

%d bloggers like this: